Beranda › Leukemia Limfoblastik Akut
Uji klinis Leukemia Limfoblastik Akut yang merekrut di AS
134 studi untuk Leukemia Limfoblastik Akut merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX28 studi
- New York City, NY24 studi
- Baldwin Park, CA21 studi
- Seattle, WA21 studi
- Chicago, IL19 studi
- Atlanta, GA19 studi
- Philadelphia, PA16 studi
- Memphis, TN16 studi
- Washington, DC16 studi
- Boston, MA15 studi
- Los Angeles, CA14 studi
- Durham, NC13 studi
- Mountain View, CA13 studi
- Cincinnati, OH12 studi
- Minneapolis, MN12 studi
- Columbus, OH11 studi
- Tampa, FL10 studi
- Salt Lake City, UT10 studi
- Portland, OR9 studi
- Baltimore, MD9 studi
- Miami, FL8 studi
- Aurora, CO8 studi
- Nashville, TN8 studi
- San Antonio, TX8 studi
- Charlotte, NC8 studi
- Edison, NJ8 studi
- Cleveland, OH7 studi
- Birmingham, AL7 studi
- Denver, CO7 studi
- Pittsburgh, PA6 studi
- Oklahoma City, OK6 studi
- Milwaukee, WI6 studi
- Detroit, MI6 studi
- Phoenix, AZ6 studi
- San Diego, CA6 studi
- St. Louis, MO6 studi
- Queens, NY6 studi
- San Francisco, CA5 studi
- Clifton, NJ5 studi
- The Bronx, NY5 studi
Berdasarkan negara bagian
- Alabama7 studi
- Arizona6 studi
- Arkansas5 studi
- California40 studi
- Colorado12 studi
- Connecticut3 studi
- Distrik Columbia10 studi
- Florida19 studi
- Georgia20 studi
- Hawaii3 studi
- Illinois20 studi
- Indiana6 studi
- Iowa5 studi
- Kansas5 studi
- Kentucky4 studi
- Louisiana6 studi
- Maine3 studi
- Maryland16 studi
- Massachusetts15 studi
- Michigan8 studi
- Minnesota14 studi
- Mississippi3 studi
- Missouri6 studi
- Nebraska4 studi
- Nevada3 studi
- New Jersey11 studi
- New Mexico3 studi
- New York32 studi
- North Carolina21 studi
- Ohio21 studi
- Oklahoma8 studi
- Oregon10 studi
- Pennsylvania21 studi
- Rhode Island3 studi
- South Carolina5 studi
- South Dakota3 studi
- Tennessee22 studi
- Texas30 studi
- Utah10 studi
- Virginia9 studi
- Washington22 studi
- West Virginia4 studi
- Wisconsin9 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
Menerima pesertaFase 1
Hingga usia 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT01853631A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
Menerima peserta
Usia 1 hingga 25 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05621291Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Menerima pesertaFase 1
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06904066Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Menerima pesertaFase 1
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07572136Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Menerima pesertaStudi observasional
Usia 0 hingga 38 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06131801CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Menerima pesertaFase 2
Usia 3 hingga 65 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07328503CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
Menerima pesertaFase 1/2
Usia 3 hingga 39 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT05442515A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Menerima pesertaFase 1
Usia 12 hingga 78 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT03802695A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Menerima pesertaFase 2
6 Months · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06514794Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06144606Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Menerima pesertaFase awal 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06398457Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
Menerima pesertaStudi observasional
4 Weeks – 18 Years · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06529575Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06308588Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06819475A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Menerima pesertaFase 1/2
30 Days · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT04065399A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
Menerima pesertaFase 1
Usia 0 hingga 18 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06173518Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06904482Cord Blood Transplant in Adults With Blood Cancers
Menerima pesertaFase 2
Usia 21 hingga 65 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT05884333Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
Menerima pesertaFase 1/2
Usia 16 hingga 75 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT03104491Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies
Menerima pesertaFase 1
Usia 1 hingga 25 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06408194First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07586618Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Hingga usia 50 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT05322850Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
Menerima pesertaFase 1
Hingga usia 21 · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT04881240CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
Menerima pesertaFase 1
Hingga usia 21 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07257419Dari ClinicalTrials.gov, data diambil 4 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.